Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Oakes

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2010
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's diseaseSteven R Schwid, Janice Bausch, David Oakes, et al.
Neurology|April 30, 2013
Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROSAnnie Killoran, Kevin M Biglan, Joseph Jankovic, et al.
Movement Disorders Clinical Practice|October 7, 2025
Prognostic Value of Parkinson's Disease Subtypes in the LABS-PD Cohort: Functional Ability, Quality of Life and MortalityDeepa Dash, Shirley Eberly, David Oakes, et al.
Pediatrics|March 4, 2003
Randomized clinical trial of pacifier use and bottle-feeding or cupfeeding and their effect on breastfeedingCynthia R Howard, Fred M Howard, Bruce Lanphear, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2021
Re-Analysis of the STEADY-PD II Trial-Evidence for Slowing the Progression of Parkinson's DiseaseD James Surmeier, Jack T Nguyen, Nicola Lancki, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2012
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome StudyAndrew Siderowf, Danna Jennings, Shirley Eberly, et al.
Neurology|July 14, 2017
The CREST-E study of creatine for Huntington disease: A randomized controlled trialSteven M Hersch, Giovanni Schifitto, David Oakes, et al.
Annals of Internal Medicine|July 20, 2005
High-dosage vitamin E supplementation and all-cause mortalityConnie Marras, Anthony E Lang, David Oakes, et al.
The New England Journal of Medicine|December 14, 2004
Levodopa and the progression of Parkinson's diseaseStanley Fahn, David Oakes, Ira Shoulson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2009
A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohortsConnie Marras, Anthony E Lang, Shirley W Eberly, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Movement Disorders : Official Journal of the Movement Disorder Society|July 30, 2010
Cancer incidence in a trial of an antiapoptotic agent for Parkinson's diseaseSteven R Schwid, Janice Bausch, David Oakes, et al.
Neurology|April 30, 2013
Characterization of the Huntington intermediate CAG repeat expansion phenotype in PHAROSAnnie Killoran, Kevin M Biglan, Joseph Jankovic, et al.
Movement Disorders Clinical Practice|October 7, 2025
Prognostic Value of Parkinson's Disease Subtypes in the LABS-PD Cohort: Functional Ability, Quality of Life and MortalityDeepa Dash, Shirley Eberly, David Oakes, et al.
Pediatrics|March 4, 2003
Randomized clinical trial of pacifier use and bottle-feeding or cupfeeding and their effect on breastfeedingCynthia R Howard, Fred M Howard, Bruce Lanphear, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 12, 2021
Re-Analysis of the STEADY-PD II Trial-Evidence for Slowing the Progression of Parkinson's DiseaseD James Surmeier, Jack T Nguyen, Nicola Lancki, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2012
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome StudyAndrew Siderowf, Danna Jennings, Shirley Eberly, et al.
Neurology|July 14, 2017
The CREST-E study of creatine for Huntington disease: A randomized controlled trialSteven M Hersch, Giovanni Schifitto, David Oakes, et al.
Annals of Internal Medicine|July 20, 2005
High-dosage vitamin E supplementation and all-cause mortalityConnie Marras, Anthony E Lang, David Oakes, et al.
The New England Journal of Medicine|December 14, 2004
Levodopa and the progression of Parkinson's diseaseStanley Fahn, David Oakes, Ira Shoulson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 13, 2009
A comparison of treatment thresholds in two large Parkinson's disease clinical trial cohortsConnie Marras, Anthony E Lang, Shirley W Eberly, et al.
Pageof 12